Literature DB >> 15791554

Severe chronic venous insufficiency: primary treatment with sclerofoam.

John J Bergan1, Luigi Pascarella.   

Abstract

Venous insufficiency, for practical purposes, can be divided into primary venous insufficiency and chronic venous insufficiency. The latter is characterized by advanced skin changes of hyperpigmentation, edema, ulceration, scarring from healed ulcers or open ulcerations. These are summarized in the CEAP classification as Classes 4, 5 and 6. Pretreatment evaluation is done with a standing ultrasound reflux examination. Thorough mapping of the extremity reflux is desirable. Physiologic tests of venous function, such as plethysmography, are unnecessary. Treatment is directed at closing refluxing axial veins as well as controlling those perforating veins with outward flow. Varicose veins contribute to axial reflux and must be obliterated. Arterial occlusive disease may complicate venous ulceration in as many as 15% of cases. Initial treatment of severe chronic venous insufficiency is usually carried out by controlling the edema with elastic bandaging or nonelastic support, such as the Unna boot or the CircAid dressing. Surgical intervention has been successful but the advent of foam sclerotherapy has proven to be an attractive alternative to surgery and has added a new tool for the treatment of severe chronic venous insufficiency. In this preliminary experience, the results are quite satisfactory and the technique has been shown to be effective, pain-free, inexpensive, with very little morbidity. Guidelines for obtaining sclerosants for use in foam sclerotherapy legally are provided.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15791554     DOI: 10.1053/j.semvascsurg.2004.12.012

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  5 in total

1.  Venous leg ulcerations: a treatment update.

Authors:  Ronda S Farah; Mark D P Davis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04

2.  Vascular sclerosing effects of bleomycin on cutaneous veins: a pharmacopathologic study on experimental animals.

Authors:  Khalid M AlGhamdi; Ashok Kumar; Abdelkader E Ashour; Ammar C Al-Rikabi; Abdullah Hasan AlOmrani; Shaik Shaffi Ahamed
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

3.  Phenol as a novel sclerosing agent: A safety and efficacy study on experimental animals.

Authors:  Khalid M Alghamdi; Abdelkader E Ashour; Ammar C Rikabi; Noura A Moussa
Journal:  Saudi Pharm J       Date:  2013-02-10       Impact factor: 4.330

4.  Treatment of chronic venous insufficiency.

Authors:  Suman W Rathbun; Angelia C Kirkpatrick
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04

5.  Impact of lower extremity venous ulcers due to chronic venous insufficiency on quality of life.

Authors:  Sotirios A Koupidis; Kosmas I Paraskevas; Vassilios Stathopoulos; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2008-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.